- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05955339
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults (CHRONICLE)
May 15, 2026 updated by: Paul J. Barr, Dartmouth-Hitchcock Medical Center
Comparing Healthcare Visit Recording and Open Notes to Improve the Chronic Illness Care Experience for Older Adults (The CHRONICLE Trial)
CHRONICLE is a randomized trial assessing the comparative effectiveness of providing written visit information via the patient portal (NOTES) versus NOTES plus visit audio recording (AUDIO) to older adult patients with chronic diseases on quality of life and other outcomes.
During the trial, the team will also invite caregivers identified by patients to join the project.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The research team is working with primary care clinics at three health systems across the country to enroll adults ages 65 and older who are managing diabetes or high blood pressure, plus one other disease.
The team is assigning patients by chance to one of two groups.
Each group will have an equal numbers of patients.
Patients in one group will get access to visit notes through the patient portal.
The research team will give patients guidance on how to find and use their visit notes.
Patients in the other group will not only have access to their visit notes patients but also get access to audio-recordings of their visits.
After each visit, patients in both groups will receive emails to review their visit information: 1) two days after their visit to remind them of their visit discussion and any tasks they may have, and 2) three days before their next visit, they will be asked to think of any changes from their last visit and to make a list of three things they want to talk to their doctor about.
The team is comparing changes reported by patients over six months in quality of life, satisfaction, self-management ability, treatment adherence, and visit communication.
The team will also invite caregivers identified by patients to join the project.
They will show patients how to share their visit notes or recordings with caregivers.
Caregivers will report on changes in how prepared they feel to provide care, burden related to caregiving, and how much they felt part of the patient's visit conversation.
Study Type
Interventional
Enrollment (Estimated)
1022
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Paul J Barr, PhD
- Phone Number: 603-646-7016
- Email: paul.j.barr@dartmouth.edu
Study Contact Backup
- Name: Renata W. Yen, PhD
- Phone Number: 603-646-5670
- Email: renata.west.yen@dartmouth.edu
Study Locations
-
-
New Hampshire
-
Manchester, New Hampshire, United States, 03104
- Recruiting
- Dartmouth Hitchcock Clinics Manchester
-
Contact:
- Paul J Bar, PhD
- Phone Number: 603-646-7016
- Email: paul.j.barr@dartmouth.edu
-
Contact:
- Renata W Yen, PhD
- Phone Number: 603-646-5670
- Email: renata.west.yen@dartmouth.edu
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Recruiting
- Vanderbit University Medical Center
-
Contact:
- Kerri L Cavanaugh, MD
- Phone Number: 615-875-2737
- Email: kerri.cavanaugh@vumc.org
-
Contact:
- Sonya Williams
- Phone Number: 615 875 2737
- Email: sonya.I.williams@vumc.org
-
-
Texas
-
Galveston, Texas, United States, 77555
- Not yet recruiting
- University of Texas Medical Branch
-
Contact:
- Meredith C Masel, PhD
- Phone Number: 409-747-6009
- Email: mcmasel@utmb.edu
-
Contact:
- Isamar Ortiz
- Phone Number: 409-266-3009
- Email: iiortiz@utmb.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
PATIENTS:
Inclusion Criteria:
- ≥ 65 years;
- With multimorbidity (diabetes or hypertension plus one of the following: arthritis (osteoarthritis and rheumatoid arthritis), asthma, atrial fibrillation, Alzheimer's disease and related dementia (not severe), cancer, chronic obstructive pulmonary disease, depression, heart disease, heart failure, hyperlipidemia, osteoporosis, kidney disease and stroke. Patients with diabetes plus hypertension are eligible.
- Have had two or more clinic visits in the previous 12 months;
- Plan on receiving ongoing care at the clinic with the enrolled clinician for the subsequent 6 months;
- Do not have vision or hearing problems that cannot be corrected; and
- Have not recorded a clinic visit for personal use in the past 6 months
Exclusion Criteria:
- With no capacity to consent to the project;
- With schizophrenia and other psychotic disorders, current substance-use disorders, uncorrected hearing or visual impairment with no adjustments to support accessing the interventions or surveys;
- Living in skilled nursing homes or hospice, because they engage less in self-management;
- With cognitive impairment as identified by a score of ≤4 on the six-item screener (SIS)
- Lacking internet access;
- Who do not speak English or Spanish;
- Who (i) do not have access to a personal email, (ii) do not have an email address shared with a family member or patient-identified caregiver, and/or (iii) are not interested in creating a personal email as this would prevent them from engaging with the intervention(s); and
- Who do not wish to create a patient portal account, if they do not already have one as this would prevent them from engaging with the intervention(s).
CAREGIVERS:
Inclusion criteria:
- Agree to their identified role as a caregiver;
- Speak English or Spanish;
- Have capacity to consent to research participation; and
- ≥ 18 years.
Exclusion criteria:
- No capacity to consent to the project;
- Living in skilled nursing homes or hospice;
- Lacking internet access; or
- Do not speak English or Spanish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: NOTES
Patients in this arm will receive only the NOTES intervention.
|
The intervention will include: (1) a brief training on using the patient portal to access written visit information with assistance in setting up patient portal accounts where necessary (including strategies to share notes with a caregiver), (2) post-visit reminders to use the patient portal to access written visit information.
|
|
Active Comparator: NOTES + AUDIO
Patients in this arm will receive both the NOTES and AUDIO intervention.
|
The intervention will include: (1) a brief training on using the patient portal to access written visit information with assistance in setting up patient portal accounts where necessary (including strategies to share notes with a caregiver), (2) post-visit reminders to use the patient portal to access written visit information.
The intervention will include: (1) audio recording all visits with the study clinician for six months, (2) training on how to record visits and access visit recordings, and (3) post-visit reminders listen to the visit recordings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life - Mental functioning
Time Frame: 6 months from enrollment
|
Quality of life using Global PROMIS (Patient-Reported Outcome Measurement Information System) is a 10-item patient reported measure with two domains: mental and physical health.
Domain scores range from 4 to 20, with higher scores representing better health.
|
6 months from enrollment
|
|
Quality of Life - Physical functioning
Time Frame: 6 months from enrollment
|
Quality of life using Global PROMIS (Patient-Reported Outcome Measurement Information System) is a 10-item patient reported measure with two domains: mental and physical health.
Domain scores range from 4 to 20, with higher scores representing better health.
|
6 months from enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-management ability
Time Frame: 6 months from enrollment
|
Self-management ability using the Patient Activation Measure-Short Form is a 13-item patient reported measure.
Scores are range from 0 (low activation) to 100 (high activation).
|
6 months from enrollment
|
|
Medication adherence
Time Frame: 6 months from enrollment
|
Medication adherence using Adherence to Refills and Medications (ARMS-7), an seven-item measure with two domains: i) medication taking and ii) medication refilling.
ARMS-7 scores range from 7 (high adherence) to 28 (low adherence).
|
6 months from enrollment
|
|
General satisfaction
Time Frame: 6 months from enrollment
|
General satisfaction using the two-item general satisfaction sub-scale from the Patient Satisfaction Questionnaire-18 (PSQ-18).
The subscale is scored as a mean of the two questions with a potential score ranging from 1 to 5. Higher scores indicate more satisfaction.
|
6 months from enrollment
|
|
Visit communication style and shared decision-making
Time Frame: 6 months from enrollment
|
Visit communication style and shared decision making using 14 items (6 of 7 subscales) from the Interpersonal Process of Care (IPC) survey.
Each of the 6 subscales has a potential score of 1 to 5. Direction of the score depends on the subscale.
|
6 months from enrollment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver preparedness [Caregiver outcome]
Time Frame: 6 months from enrollment
|
Caregiver preparedness using the 9-item Preparedness for Caregiving Scale.
Scores range from 0 to 4 with higher scores corresponding to caregivers feeling more prepared for caregiving.
|
6 months from enrollment
|
|
Caregiver burden [Caregiver outcome]
Time Frame: 6 months from enrollment
|
Caregiver burden using the 10-item Burden Scale for Family Caregivers-Short Form (BSFC-s).
BSFC-s scores range from 0 to 30 with higher scores indicating greater caregiver burden.
|
6 months from enrollment
|
|
Caregiver engagement in clinic visit [Caregiver outcome]
Time Frame: 6 months from enrollment
|
Caregiver engagement in clinic visit using the 12-item CAregiver Perceptions About CommunIcaTion with Clinical Team members (CAPACITY).
Potential scores range from 12 to 48 with higher score indicating perceptions of better quality communication and capacity-assessment from the care team.
|
6 months from enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Paul J Barr, PhD, Dartmouth College
- Principal Investigator: Kerri L Cavanaugh, MD, Vanderbilit University Medical Center
- Principal Investigator: Meredith C Masel, PhD, University Texas Medical Branch
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2024
Primary Completion (Estimated)
April 7, 2027
Study Completion (Estimated)
June 14, 2027
Study Registration Dates
First Submitted
July 12, 2023
First Submitted That Met QC Criteria
July 13, 2023
First Posted (Actual)
July 21, 2023
Study Record Updates
Last Update Posted (Actual)
May 18, 2026
Last Update Submitted That Met QC Criteria
May 15, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY02002056
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Upon completion of this research, the research data from this project will be deposited with the Patient-Centered Outcomes Data Repository (PCODR), based at the Inter-university Consortium for Political and Social Research (ICPSR), University of Michigan to ensure that the research community has long-term access to the data.
This will include all deidentified data from surveys and/or transcripts from recorded interviews or encounters.
For those who consent, we will also put identifiable recordings into the repository.
IPD Sharing Time Frame
At the completion of data analysis.
IPD Sharing Access Criteria
All access will be coordinated through PCODR/ICPSR.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on NOTES
-
The Oregon ClinicNorthwestern UniversityCompletedCholecystitisUnited States
-
Heidelberg UniversityCompleted
-
Hadassah Medical OrganizationCompleted
-
University Hospitals Cleveland Medical CenterCompletedProstatic Diseases | Gastric Foreign Body, Nos | Disorder of Abdomen (Disorder) | Foreign Body in Esophagus | Disease of Small IntestineUnited States
-
Hospital Son LlatzerCompleted
-
The Royal Wolverhampton Hospitals NHS TrustCompletedCardiopulmonary ResuscitationUnited Kingdom
-
Ethicon Endo-SurgeryCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompleted
-
Herlev HospitalUniversity of Copenhagen; Bispebjerg Hospital; University Hospital, Gentofte,...TerminatedPain | Surgery | CholecystolithiasisDenmark
-
University of California, San DiegoUnknownVentral Hernia | Umbilical HerniaUnited States